Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.35
Delayed Data
As of Aug 22
 0.00 / 0.00%
Today’s Change
0.27
Today|||52-Week Range
0.89
-3.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues95.0K0.000.000.00
 
 
Depreciation And Amortization110.0K109.0K20.0K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income---109.0K-20.0K-19.0K
 
 
 
 
General Expenses8.3M12.5M13.7M13.7M
 
 
 
 
 
Research And Development3.6M7.4M9.1M8.8M
 
 
 
 
 
Total Operating Expenses8.4M12.7M13.7M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.3M-12.7M-13.7M-13.8M
 
 
 
 
 
Other Expenses-1.0K-3.0K1.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M-12.6M-13.7M-13.7M
 
 
 
 
 
Preferred Dividend-4.8M0.000.000.00
 
 
Net Income-8.3M-12.6M-13.7M-13.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.8M17.0M25.2M26.5M
 
 
 
 
 
Shares To Calculate EPS Diluted2.8M17.0M25.2M26.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.67-$0.75-$0.54-$0.51
 
 
 
 
 
EPS Diluted-$4.67-$0.75-$0.54-$0.51